Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used
被引:10
作者:
Anderegg, TR
论文数: 0引用数: 0
h-index: 0
机构:JMI Labs Inc, Jones Grp, N Liberty, IA 52317 USA
Anderegg, TR
Jones, RN
论文数: 0引用数: 0
h-index: 0
机构:JMI Labs Inc, Jones Grp, N Liberty, IA 52317 USA
Jones, RN
Sader, HS
论文数: 0引用数: 0
h-index: 0
机构:JMI Labs Inc, Jones Grp, N Liberty, IA 52317 USA
Sader, HS
机构:
[1] JMI Labs Inc, Jones Grp, N Liberty, IA 52317 USA
BAL9141 is a novel cephalosporin with a broad spectrum of activity, including activity against methicillin-resistant staphylococci. This multicenter study was performed to establish quality control (QC) guidelines for susceptibility testing of BAL9141 in phase 3 clinical trials and after U.S. Food and Drug Administration approval. The proposed 3 or 4 log, dilution MIC ranges encompass 97.8 to 100.0% of reported results, while the proposed 7- to 9-mm-zone-diameter QC ranges included 95.2 to 99.4% of the participant-reported disk diffusion results.